FIDSON logo

Fidson Healthcare Stock Price

Symbol: NGSE:FIDSONMarket Cap: ₦100.8bCategory: Pharmaceuticals & Biotech

FIDSON Share Price Performance

Recent FIDSON News & Updates

No updates

Fidson Healthcare Plc Key Details

₦100.3b

Revenue

₦61.3b

Cost of Revenue

₦39.0b

Gross Profit

₦31.1b

Other Expenses

₦8.0b

Earnings

Last Reported Earnings
Mar 31, 2025
Next Reporting Earnings
n/a
Earnings per share (EPS)
3.48
Gross Margin
38.93%
Net Profit Margin
7.97%
Debt/Equity Ratio
119.3%

Fidson Healthcare Plc Competitors

 
 
 
 
 
 
 
 
 
 
 
 

About FIDSON

Founded
1995
Employees
674
CEO
Fidelis Ayebae
WebsiteView website
fidson.com

Fidson Healthcare Plc manufactures and distributes pharmaceutical products in Nigeria. The company operates in three segments: Over-the-Counter, Ethical Products, and Consumer Healthcare Product. It offers drugs, infusions, and injectables. The company also provides products for anti infective and anti malaria, central nervous system, and cough and cold, gastrointestinal medicines; supplements; topical/dermatological medicines; vitamins and minerals; and ophthalmic solutions. Fidson Healthcare Plc was incorporated in 1995 and is headquartered in Lagos, Nigeria.

Nigerian Market Performance

  • 7 Days: 2.8%
  • 3 Months: 27.7%
  • 1 Year: 41.3%
  • Year to Date: 30.5%
The market is up 2.8% over the last week, with the Consumer Staples sector leading the way, up 5.1%. In the last year, the market has climbed 41%. Looking forward, earnings are forecast to grow by 12% annually. Market details ›
Companies across the globe are beginning to pay attention to agentic AI. It’s also a term you’re likely to hear a lot during earnings season. In fact, it came up 26 times during...
Continue reading